Business
ChromaDex to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020
LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs., August 6, 2020 at 4:30 p.m. ET to
About this update from Niagen Bioscience, Inc.
[{"type":"text","content":" LOS ANGELES--(BUSINESS WIRE)--\nChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs., August 6, 2020 at 4:30 p.m. ET to discuss its financial results for the second quarter ended Jun. 30, 2020. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.\n\n\nInvestor Conference Call:\n\n\nChromaDex management will host an investor conference call to discuss the second quarter results and provide a general business update on Thurs., August 6, at 4:30 p.m. ET.\n\n\nParticipants should call in at least 10 minutes prior to the call. The dial-in information is as follows:\n\n\nDate: Thurs., August 6, 2020\nTime: 4:30 p.m. ET (1:30 p.m. Pacific time)\nToll-free dial-in number: 1-833-979-2703\nInternational dial-in number: 236-714-2223\nConference ID: 1563949\nWebcast link: ChromaDex Second Quarter 2020 Earnings Conference Call\n\n\nThe conference call will be broadcast live and available for replay here and via the investor relations section of the Company’s website at www.chromadex.com.\n\n\nA replay of the conference call will be available after 7:30 p.m. ET.\n\n\nToll-free replay number: 800-585-8367\nReplay ID: 1563949\n\n\nAbout ChromaDex:\n\n\nChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of NAD and its impact on human health. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.\n\n\nForward-Looking Statements:\n\n\nThis release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not alwa...